884 related articles for article (PubMed ID: 32602908)
1. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
Niraula S; Biswanger N; Hu P; Lambert P; Decker K
JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
[TBL] [Abstract][Full Text] [Related]
3. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
4. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in women with interval breast cancer: population based observational cohort study.
Kalager M; Tamimi RM; Bretthauer M; Adami HO
BMJ; 2012 Nov; 345():e7536. PubMed ID: 23160783
[TBL] [Abstract][Full Text] [Related]
6. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
8. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
[TBL] [Abstract][Full Text] [Related]
9. Molecular comparison of interval and screen-detected breast cancers.
Cheasley D; Li N; Rowley SM; Elder K; Mann GB; Loi S; Savas P; Goode DL; Kader T; Zethoven M; Semple T; Fox SB; Pang JM; Byrne D; Devereux L; Nickson C; Procopio P; Lee G; Hughes S; Saunders H; Fujihara KM; Kuykhoven K; Connaughton J; James PA; Gorringe KL; Campbell IG
J Pathol; 2019 Jun; 248(2):243-252. PubMed ID: 30746706
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Screening, Incidence, and Mortality Across US Counties.
Harding C; Pompei F; Burmistrov D; Welch HG; Abebe R; Wilson R
JAMA Intern Med; 2015 Sep; 175(9):1483-9. PubMed ID: 26147578
[TBL] [Abstract][Full Text] [Related]
11. Diet-Driven Inflammation and Insulinemia and Risk of Interval Breast Cancer.
Zhang Z; Tabung FK; Jin Q; Curran G; Irvin VL; Shannon J; Velie EM; Manson JE; Simon MS; Vitolins M; Valencia CI; Snetselaar L; Jindal S; Schedin P
Nutr Cancer; 2022; 74(9):3179-3193. PubMed ID: 35471124
[TBL] [Abstract][Full Text] [Related]
12. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
[TBL] [Abstract][Full Text] [Related]
14. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
[TBL] [Abstract][Full Text] [Related]
15. Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis.
Bellio G; Marion R; Giudici F; Kus S; Tonutti M; Zanconati F; Bortul M
Clin Breast Cancer; 2017 Nov; 17(7):564-571. PubMed ID: 28456487
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer.
Song H; Tran TXM; Kim S; Park B
JAMA Netw Open; 2024 May; 7(5):e2411927. PubMed ID: 38767918
[TBL] [Abstract][Full Text] [Related]
17. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
18. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
[TBL] [Abstract][Full Text] [Related]
19. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative.
Cespedes Feliciano EM; Hohensee C; Rosko AE; Anderson GL; Paskett ED; Zaslavsky O; Wallace RB; Caan BJ
JAMA Netw Open; 2020 Sep; 3(9):e2016747. PubMed ID: 32926116
[TBL] [Abstract][Full Text] [Related]
20. Five-Year Overall Survival of Interval Breast Cancers is Better than Non- Interval Cancers from Korean Breast Cancer Registry.
Lee JS; Kim HA; Cho SH; Lee HB; Park MH; Jeong J; Park HK; Oh M; Yi O
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1717-1726. PubMed ID: 31244292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]